Press "Enter" to skip to content

Tag: research

In a nationwide survey on COVID-19 smell loss, over 50% of respondents still have symptoms after five years

The VCU-led study highlights the pervasiveness of COVID-19 smell loss as a chronic condition rather than just a temporary symptom of infection.

Since the early stages of the COVID-19 pandemic, researchers at Virginia Commonwealth University’s School of Medicine have maintained a national database of patients affected by COVID-19 related smell loss. Their latest survey shows that more than half of respondents are still impacted by smell dysfunction five years after initial infection.

The preliminary report, published in the journal Otolaryngology–Head and Neck Surgery, represents the longest study on COVID-19 smell loss recovery to date.

“Our data shows that many people are still experiencing the health impacts of COVID-19 even several years later, and they are still looking for help for their symptoms,” said Richard Costanzo, Ph.D., a professor emeritus in the Department of Otolaryngology at the School of Medicine and co-author of the new study. “We need to find new ways to help people suffering from smell and taste disorders, whether that’s caused by COVID-19 or any future viruses.”

Comments closed

Common diabetes drug linked to lower risk of death after COVID infection

People with type 2 diabetes who were taking the drug metformin when they contracted COVID-19 had a 39% lower risk of dying over the following year than peers who were taking a different diabetes medication, according to a study published last week in Diabetes, Obesity and Metabolism.

The study also found that those who were taking metformin, a medication that helps lower blood sugar and improve insulin sensitivity, had a slightly reduced but non-statistically significant risk of long COVID.

Comments closed

Rare Blood Clots After Certain COVID Vaccines, Explained

Mutations both inherited and spontaneous created bad antibodies that went off-target.

The light at the end of the pandemic tunnel was marred by a worrying shadow. As the COVID-19 vaccines were rolled out, headlines fuelled anxiety: some people were developing life-threatening blood clots after receiving either the Johnson & Johnson vaccine (made by one of its subsidiaries, Janssen Vaccines) or the Oxford-AstraZeneca shot. This serious complication was almost only seen with these two vaccines, although one person who received the Moderna vaccine and one who was vaccinated with the Pfizer shot also received the same diagnosis.

The anti-vaccine movement took this real observation and stretched it out of proportion, accusing all COVID vaccines of killing large swaths of the population through deadly coagulation.

The actual issue was very rare and quite narrow, though still distressing. Based on a survey of what was reported in the scientific literature, 137 people worldwide are known to have died from blood clots following COVID vaccine injection, six of whom died in Canada. Shortly after the problem was identified, health authorities revised their vaccine recommendations. Johnson & Johnson halted production of its vaccine in February 2022; AstraZeneca withdrew its vaccine worldwide in May 2024.

Comments closed

EU representative praises closer work with Canada on vaccines as U.S. pulls back

OTTAWA – The European Union is working more closely with Canada on creating, stockpiling and researching vaccines as the United States pulls back, says a senior official from Brussels.

“Our production, research and development capabilities, and how we communicate about our existing (vaccine) stock, are extremely sensitive matters,” European Crisis Management Commissioner Hadja Lahbib said in a French-language interview Monday in Ottawa.

“Canada is the only country outside the European Union with which we do this.”

Comments closed

‘Zombified’ C.D.C., Hobbled by Cuts, Struggles to Fulfill Scientific Mission

The agency has lost its independence and nearly a third of its staff, as Health Secretary Robert F. Kennedy Jr. and associates have tightened control.

For decades, the Centers for Disease Control and Prevention was the undisputed global leader in public health. Its scientists helped train health officials worldwide. In the United States, it was the primary source of guidance for prevention and treatment of diseases, including diabetes, H.I.V. and the seasonal flu.

But after a year and a half in the cross hairs of Health Secretary Robert F. Kennedy Jr.’s drive to remake public health policy, the agency is a skeleton of the powerhouse it was.

The Trump administration’s widespread layoffs in early 2025 cut 18 percent of the C.D.C.’s staff. But new personnel data, compiled by a group of former federal scientists and reported here for the first time, indicate that the agency’s staff has dwindled far more, as large numbers of employees retired or resigned. As of May 2026, the C.D.C. had 30 percent fewer employees than it did before the layoffs, the data show.

Comments closed

Abandoned, dismissed and gaslighted: there is no excuse for the way ME sufferers have been betrayed

Changes in guidance and science seem to have little impact on millions of devastated lives. It’s a shocking social crisis playing out behind closed doors

I’ve spent my working life covering neglected issues. But few are neglected like the devastating chronic condition ME/CFS (myalgic encephalomyelitis, or chronic fatigue syndrome). In severe cases, the illness shuts down people’s lives almost entirely, causing an extreme loss of energy and a wide range of physical and cognitive symptoms that can prevent patients from working, socialising and, sometimes, even moving or eating. Yet these people have been more or less airbrushed from our minds.

To find out what this neglect looks like in practice, this week I put out a call on Bluesky asking people with ME/CFS about their recent experiences of treatment. I was immediately inundated with horrifying testimonies. “I’ve just been completely abandoned”; “a 10-year waiting list for treatment”; “we’ve given up seeking medical support”; “stuck in limbo”; “I just felt utterly unheard, invalidated”. I’ve been sent hundreds of shocking and heart-rending accounts.

Comments closed

‘Outdated’ health policies surrounding Covid still pose a danger today, says U of C researcher

University of Calgary professor Mark Ungrin has dedicated years of research highlighting what he believes is of significant concern to all Canadians’ health.

He says health policy and the federal government’s response to Covid was based on outdated information, and even today that same policy remains in place.

“Unfortunately, when Covid hit, there was very little attention paid to aerosol transmission as a means of Covid infecting from one person to another,” Ungrin said. “Warnings were provided by scientists, engineers, occupational health and safety experts, many people within the medical profession, but infection control leaders really based their decisions on some fairly outdated understandings of aerosol biology and disease transmission via aerosols, and as a result, they basically assumed that it was not possible for Covid to be airborne.”

Comments closed

Why Is No One Talking About Long COVID?

More than 6 years after the COVID-19 pandemic began, its effects have continued. In March 2024, roughly 17 million adults (7% of all U.S. adults) reported currently having symptoms consistent with long COVID, a chronic condition characterized by persistent symptoms lasting 3 months or longer after infection. Long COVID can affect any system or organ in the body. Symptoms of long COVID include chronic fatigue, brain fog, difficulty concentrating, severe tiredness after exercise, lightheadedness and palpitations when standing, and many other problems. Those chronic symptoms often make it difficult for people to go to work or school.

As a result, long COVID imposes substantial disability. In fact, researchers have estimated that years lived with disability attributable to long COVID is comparable to other common diseases like Alzheimer’s and asthma. In addition to the immediate effects on patients and their families, that disability translates into profound economic losses. Economists estimated in 2022 that the costs of long COVID will result in more than $3 trillion lost to society over 5 years, either through reduced quality of life and increased medical care or through lost economic productivity.

Comments closed

20 years. Millions of lives saved. One revolutionary vaccine

Twenty years ago, the first dose of a UQ-developed vaccine was given to a teenage girl in Brisbane. That same vaccine is now on track to end cervical cancer in Australia.

August 28, 2026, marks the 20th anniversary of the first dose of the human papillomavirus (HPV) vaccine – now known as Gardasil 9 – which immunises recipients against the virus that is the leading cause of cervical cancer.

The vaccine, developed by Emeritus Professor Ian Frazer AC and the late Dr Jian Zhou, is now offered to all children aged 12-13 years old through the school-based National Immunisation Program.

Worldwide, more than 600 million doses of Gardasil have been administered.

Comments closed

‘I couldn’t breathe’: the deadly health burden of wildfire smoke

Scientists race to untangle complex links between exposure and mortality as fire weather grows more prevalent

A thousand kilometres from the infernos gorging on northern Ontario’s boreal forests, Erin O’Connor watched the sky above Canada’s biggest city turn an “almost post-apocalyptic” orange as it filled with light-scattering particles of soot and ash. Stepping outside the halls of Toronto General hospital, where air filters were keeping patients safe from the worst of the fumes, she was struck by a smell so strong it felt like standing by a campfire.

“It really hit you in the face as soon as you walked outside,” said O’Connor, who runs University Health Network’s emergency department and saw a rise in patients presenting with allergies and shortness of breath. “As the days progressed, it was like that everywhere. It seemed even inside you could smell that burning.”

Far more than the flames that have engulfed southern Europe and North America in recent weeks, it is the smoke that dominates the astonishing death toll from combusting nature. Thick with toxic gases that inflame the airways and tiny particulates that breach the lungs and ride the bloodstream to hit every organ in the body, fumes from landscape fires kill 1.5 million people each year, a study in the Lancet found in 2024 – more than floods, flames, storms and heat combined.

Comments closed

New Study Provides First Evidence of Dopamine System Injury in the Brain of Long COVID Patients

Findings have important implications for the pathophysiology of key COVID symptoms and suggest new potential avenues for treatment

Toronto, ON (July 10, 2026) — A new brain imaging study led by researchers at the Centre for Addiction and Mental Health (CAMH), published in eBioMedicine, provides the strongest evidence to date that long COVID is associated with injury to dopamine-releasing neurons in the brain—a finding that may explain symptoms such as lack of motivation due to fatigue, slowed movement, and memory difficulties, and could open the door to new treatment strategies.

Long COVID is estimated to affect five per cent of the world population, including two million Canadians, and is characterized by a wide range of persistent and sometimes debilitating symptoms, including brain-related ones such as fatigue, brain fog, memory problems, or low mood, that continue for at least three months following the initial COVID-19 infection. Despite its prevalence, no evidence-based treatments currently exist, largely due to limited understanding of the underlying brain pathology.

In the new study, researchers used positron emission tomography (PET) brain imaging to measure a well-established marker of dopamine neuron integrity in people with long COVID and healthy individuals.

Comments closed

Buildings May Soon Have ‘Immune Systems’ That Fight Airborne Disease

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

Linsey Marr, an environmental engineer, stood next to a pair of clear plastic boxes packed with tubes, nozzles and electronics, an odd-looking prototype that one day might serve to protect children in day care from airborne pathogens.

A nozzle filled the right-hand box with a faint silvery mist. A pump pulled some of that air into the left-hand box, where a sampler trapped floating particles and droplets. Soon, a digital screen bolted to the box turned red: “Detected! Dust mite allergen Der f 1.”

A protein shed by dust mites, Der f 1 can trigger asthma attacks when inhaled. Dr. Marr’s device had detected 843 picograms of Der f 1 per cubic meter. A single grain of salt is about 10 million times as heavy.

Comments closed

Long COVID may affect 1 in 6 infected patients

Long COVID may be affecting far more Americans than current estimates suggest, with a study published last week in JAMA Network Open estimating that roughly one in six people infected with SARS-CoV-2 develop the condition, and nearly 90% go on to experience chronic health problems.

For the study, a team led by researchers at Massachusetts General Hospital analyzed health record data from 457,950 adults treated for COVID-19 (also known as postacute sequelae of SARS-CoV-2 infection, or PASC) across 58 hospitals and clinics in New England, Southeast Texas, Southern California, and Western Pennsylvania.

The researchers identified long COVID cases by detecting symptoms and conditions that emerged after infection and could not be explained by preexisting conditions.

Comments closed

Seasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada

An interim analysis published in Eurosurveillance estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine’s target strain.

Seasonal COVID-19 vaccination is recommended in Canada as in several other countries for people older than 6 months with an increased risk of severe illness from the infection, and for all adults aged 65 or older. In the 2025/26 respiratory virus season, the vaccine was updated to target the LP.8.1 strain as recommended by the World Health Organization (WHO), but other strains were also circulating during that period.

Comments closed

HHS rejects publication of study showing Covid-19 vaccines prevent hospitalizations, ER visits

Covid-19 vaccines roughly halved the chances that a US adult would need to visit the emergency room or be hospitalized with their infections last fall and winter, according to two sources familiar with the findings of a new study. But you won’t hear about it from the agency that led the research: the US Centers for Disease Control and Prevention.

The current head of the CDC, Dr. Jay Bhattacharya, who’s also director of the US National Institutes of Health, blocked the publication of those findings in the CDC’s flagship journal, the Morbidity and Mortality Weekly Report, according to the sources.

The authors of the study received an official rejection letter from the journal on Tuesday, one source said, even though the study had cleared internal reviews and had been scheduled for publication.

Comments closed

Common antidepressant can treat long COVID fatigue symptoms: study

A common and low-cost antidepressant can successfully treat fatigue associated with long COVID, according to a new study.

Co-led by researchers from McMaster University in Ontario, the study found that the drug fluvoxamine, which is commonly sold under the name Luvox, significantly reduced fatigue symptoms in a clinical trial of 399 adults with long COVID. It is one of the first times a medication has been shown to effectively treat the condition.

“This is an important step forward for patients who have been desperate for evidence‑based options,” senior author and McMaster University professor Edward Mills said in a news release.

Comments closed

Study: SARS-CoV-2 RNA found in 39% of hospital air samples during outbreaks, despite good ventilation

COVID-19 genetic material was frequently detected in hospital air during community outbreaks, even in well-ventilated settings, according to a new study published in Respiratory Medicine.

A team led by Kirby Institute researchers conducted air and surface sampling in the emergency department (ED) and intensive care unit (ICU) of a large metropolitan hospital in Sydney, Australia, during two COVID-19 waves between November 2023 and July 2024. Their testing found that 39% (20 of 51) of aerosol samples were positive for SARS-CoV-2 RNA.

Detection was significantly more common in the ED than in the ICU. Of the positive samples, 80% were collected in the ED and 20% in the ICU.

Comments closed